CEL-SCI Corp Files 8-K on Shareholder Vote Matters
Ticker: CVM · Form: 8-K · Filed: Apr 19, 2024 · CIK: 725363
Sentiment: neutral
Topics: shareholder-vote, corporate-governance, filing-notification
TL;DR
CEL-SCI had a shareholder vote, details to follow.
AI Summary
CEL-SCI Corporation filed an 8-K on April 19, 2024, to report on matters submitted to a vote of security holders. The filing does not contain specific details about the vote's outcome or the proposals presented, but it serves as an official notification of the event.
Why It Matters
This filing indicates that CEL-SCI Corporation has held or is holding a shareholder vote, which could potentially lead to changes in corporate governance or strategic direction.
Risk Assessment
Risk Level: low — The filing is a procedural notification of a shareholder vote and does not contain information that immediately impacts the company's financial health or operations.
Key Numbers
- 001-11889 — Commission File Number (Identifies the company's SEC filings)
- 84-0916344 — IRS Employer Identification No. (Company's tax identification number)
Key Players & Entities
- CEL-SCI Corporation (company) — Registrant
- April 19, 2024 (date) — Date of Report
- Colorado (jurisdiction) — State of Incorporation
- Vienna, VA (location) — Address of principal executive offices
FAQ
What specific matters were submitted for a vote of security holders?
The filing does not specify the exact proposals or matters submitted for a vote, only that such matters were presented.
When did the shareholder vote take place or is scheduled to take place?
The filing is dated April 19, 2024, and reports on matters submitted to a vote, implying the event occurred on or around this date.
What is the outcome of the shareholder vote?
The 8-K filing does not disclose the results or outcome of the shareholder vote.
What is CEL-SCI Corporation's primary business?
CEL-SCI Corporation is in the business of Biological Products (No Diagnostic Substances).
Where is CEL-SCI Corporation's principal executive office located?
The principal executive offices are located at 8229 Boone Blvd., #802, Vienna, VA 22182.
Filing Stats: 476 words · 2 min read · ~2 pages · Grade level 12.3 · Accepted 2024-04-19 16:51:50
Filing Documents
- cvm_8k.htm (8-K) — 35KB
- 0001654954-24-004820.txt ( ) — 152KB
- cvm-20240419.xsd (EX-101.SCH) — 6KB
- cvm-20240419_lab.xml (EX-101.LAB) — 14KB
- cvm-20240419_cal.xml (EX-101.CAL) — 1KB
- cvm-20240419_pre.xml (EX-101.PRE) — 9KB
- cvm-20240419_def.xml (EX-101.DEF) — 2KB
- cvm_8k_htm.xml (XML) — 4KB
07. Submission of Matters to a Vote of Securities Holders
Item 5.07. Submission of Matters to a Vote of Securities Holders. The annual meeting of CEL-SCI's shareholders was held on April 19, 2024. At the meeting the following persons were elected as directors for the upcoming year: Name Votes For Votes Against Broker Non-Votes Geert Kersten 12,694,041 1,431,331 12,800,581 Bruno Baillavoine 12,035,656 2,089,716 12,800,581 Robert Watson 12,272,038 1,853,334 12,800,581 At the meeting the following were approved by CEL-SCI's shareholders: (2) the adoption of CEL-SCI's 2024 Non-Qualified Stock Option Plan; and (3) to ratify the appointment of BDO USA, P.C. as CEL-SCI's independent registered public accounting firm for the fiscal year ending September 30, 2024. The following is a tabulation of votes cast with respect to proposals 2 and 3: Proposal Votes For Votes Against Abstain Broker Non-Votes (2) 11,195,928 2,360,433 569,011 12,800,581 (3) 26,202,822 420,335 302,796 0 2
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: April 19, 2024 CEL-SCI CORPORATION By: /s/ Geert Kersten Geert Kersten Chief Executive Officer 3